miR-33 regulates the major risk factors of atherosclerosis, including lipid metabolism (cholesterol homeostasis, HDL biogenesis, phospholipid and triglyceride, fatty acid, and bile acid metabolism), inflammatory response, glucose/energy homeostasis and insulin signaling, cell cycle progression and proliferation, and myeloid cell differentiation [39]. This evidence concerns the gene INS and atherosclerosis.